About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Bitcoin soars above $11,000 for the first time in 15 months — now up 170% for the year
- US secretary of state seeks global coalition in the Middle East against Iran amid rising tensions
- Asia Pacific trade pact can go on without India 'for the time being:' Malaysian PM Mahathir
- Goldman Sachs is offering 'peanuts' to compensate for 1MDB, says Malaysian prime minister
- American Airlines CEO says politics a factor in return of Boeing's 737 Max
NBR on TwitterMy Tweets
Subscribe to RSS
U.S. health officials confirmed another 78 cases of measles last week, urging people to vaccinate as they battle the worst year for the disease in 25 years.
Walgreens is increasing the age to buy tobacco at its drugstores to 21 later this year as the retailer faces possible sanctions from the Food and Drug Administration for allegedly selling to minors.
UnitedHealth Group shares fell for a second straight day Wednesday, weighed down by concerns over possible changes to the U.S. health-care system, including creating a government-run system to provide health insurance for all Americans.
Johnson & Johnson’s mounting legal costs ate into its first-quarter profits, which dropped 14% as it fights thousands of lawsuits over its talc baby powder and shelled out almost $400 million to settle 25,000 cases over its blockbuster blood thinner Xarelto.
UnitedHealth Group CEO David Wichmann warns that “Medicare for All” would “destabilize the nation’s health system.”
Sanofi said Wednesday it will sell monthly supplies of insulin for a fixed price of $99 for patients paying with cash in the U.S. as the pharmaceutical giant faces intense pressure from the Trump administration and Congress to lower the cost of its nearly 100-year-old, life-saving medication.
Executives from the nation’s largest pharmacy benefit managers denied Tuesday that the industry’s so-called “backdoor deals” with drug manufacturers are responsible for the increasingly higher prices patients pay for medication, pointing the finger at Big Pharma instead.
The roughly $17B deal adds to the flurry of health industry mergers in 2019. Bertha Coombs reports.
Health researchers say there’s little evidence to show that recent progress is a result of the White House’s efforts. They noted that prescriptions have been declining since 2012, before Trump became president.
In the wake of skyrocketing use of tobacco products among youth, the FDA has drafted a set of guidelines that they hope will remedy the problem. Aditi Roy reports.
Outgoing FDA chief Scott Gottlieb releases a much-anticipated draft policy restricting e-cigarette sales to curb an “epidemic” of teen use.
The “Medicare-for-all” proposal, introduced by Rep. Pramila Jayapal, D-Wash., will face backlash from critics who have warned about its potentially enormous cost.
CVS Health is unveiling its new health-focused concept store that’s designed to help the drugstore become more like a health-care provider than a place to pick up prescriptions and greeting cards.
Kate Rogers reports from a community in rural Maine that’s dealing with an issue plaguing much of the country—a shortage of EMTs and paramedics.
The health care industry experienced a number of medical breakthroughs in 2018, including for hemophilia treatment. Meg Tirrell reports.